Larvol Delta - The-Company-expects-to-present-potential-longterm-survival-data-from-arm-C-of-its-phase-1b-clinical-trial-of-linoserpaturev-in-patients-with-recurrent-highgrade-glioma-rHGG-in-Q4-2026

linoserpaturev (CAN-3110) - Candel Therap

https://www.manilatimes.net/2026/08/13/tmt-newswire/globenewswire/candel-therapeutics-reports-second-quarter-2026-financial-results-and-recent-corporate-highlights/2404867/amp

Aug 13, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next